ReviewJournal of hematology & oncology2021

The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers.

Lingling Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.